Top 10 Start-Up Venture Financings, Q2 2014
This article was originally published in Start Up
Ten biotech start-ups reaped the biggest venture rounds in Q2, according to Informa’s Strategic Transactions. Nine of the top 10 companies raised more than $30 million.
You may also be interested in...
In Vivo's editors pick January's most significant deals, including Roche's acquisition of Flatiron and Moderna's latest big private fundraising. (Free article.)
In Vivo's editors pick January's most significant deals, including an alliance of players new to health care and Celgene's big buys. (Free article.)
We nominated 15 deals in three categories. You picked the winners.